Compound class:
Synthetic organic
Comment: MI-3 inhibits the interaction between MLL oncoproteins (re-arranged lysine (K)-specific methyltransferases) and the tumour suppressor protein menin (MEN1, O00255) [1]. MI-3 represents a novel molecular mechanism with potential application in the treatment of aggressive leukemias with MLL rearrangements.
|
|
Bioactivity Comments |
MI-3 inhibits the MLL-menin interaction with an IC50 value of 648nM, binding to menin with a dissociation constant (Kd) of 201nM [1]. |